Canadian Screening Guidelines MCCQE: High Yield Facts

Preventive health screening questions feature on every session of the Medical Council of Canada Qualifying Examination (MCCQE) Part 1. The questions are based strictly on the recommendations of the Canadian Task Force on Preventive Health Care (CTFPHC). This guide summarizes the high-yield screening ages and intervals you must memorize to pass the exam.

Key Takeaways

• The Canadian Task Force on Preventive Health Care (CTFPHC) guidelines are the sole standard for screening questions on the MCCQE (CTFPHC, 2026).
• Cervical cancer screening starts at age 25 in Canada, which is a major difference from other international guidelines.
• Breast cancer screening with mammography is recommended every 2 to 3 years for women aged 50 to 74.

High-Yield Summary of Canadian Screening Guidelines

In 2026, preventive care questions test your ability to recall the exact screening age ranges and modalities recommended by the CTFPHC (CTFPHC Guidelines, 2026). If you answer these questions based on guidelines from other countries, you will lose points.

The table below summarizes the key guidelines for average-risk, asymptomatic individuals:

Prostate cancer screening is a common trap. The CTFPHC recommends against routine PSA screening for all men, regardless of age, because the harms of overdiagnosis and treatment outweigh the small benefit. On the exam, do not order a PSA test for an asymptomatic man unless he explicitly requests it after a discussion of risks.

master all high-yield subjects

Cervical and Breast Cancer Screening Details

In 2026, the SOGC and CTFPHC guidelines state that cervical cancer screening is not recommended for women under 25 years old (CTFPHC, 2026). For women aged 25 to 69, screening is performed every 3 years with a Pap test.

• When to Stop: You stop screening at age 70 if the patient has had three consecutive negative tests in the last 10 years. If the patient has not been adequately screened, you continue screening until three negative tests are documented.

For breast cancer, the guidelines recommend mammography screening every 2 to 3 years for women aged 50 to 74.

• The 40 to 49 Age Group: The CTFPHC recommends against routine screening for women aged 40 to 49. If a patient in this age group requests screening, you must engage in shared decision-making, discussing the high rate of false positives and the potential for unnecessary biopsies.

I remember a practice vignette where a 42-year-old woman with no family history requested a mammogram. The correct answer was to engage in shared decision-making and discuss the potential harms of screening, rather than simply ordering the test or refusing it.

For acute OBGYN management and prenatal schedules, refer to:

• OBGYN cheat sheet
• routine prenatal care milestones

Colorectal and Lung Cancer Screening Details

According to 2026 lung cancer screening guidelines, screening is reserved for individuals with a significant smoking history (CTFPHC, 2026). The recommendation is to screen adults aged 55 to 74 who have a 30 pack-year smoking history, and who currently smoke or quit within the last 15 years. The screening method is an annual low-dose chest CT for 3 consecutive years.

For colorectal cancer, screening is recommended for average-risk adults aged 50 to 74. The preferred method is a fecal immunochemical test (FIT) or fecal occult blood test (FOBT) every 2 years. Alternatively, a flexible sigmoidoscopy can be performed every 10 years.

The CTFPHC recommends against using colonoscopy as a primary screening tool in average-risk individuals. Colonoscopy is reserved as a diagnostic follow-up if a FIT or sigmoidoscopy result is positive.

For public health immunization and reporting guidelines, consult:

• public health cheat sheet

Frequently Asked Questions

Why does cervical screening start at age 25 in Canada?

The CTFPHC delayed the starting age to 25 because the incidence of cervical cancer in women under 25 is extremely low, and screening often leads to unnecessary treatments that can cause pregnancy complications (CTFPHC, 2026).

Is colonoscopy a recommended screening test for colorectal cancer?

No. The CTFPHC recommends FIT, FOBT, or flexible sigmoidoscopy for average-risk individuals. Colonoscopy is not recommended as a primary screening test, but is used if other screening tests are positive (CTFPHC, 2026).

When do you screen for lung cancer?

You screen adults aged 55 to 74 with at least a 30 pack-year history of smoking who currently smoke or quit in the last 15 years, using annual low-dose CT for 3 years (CTFPHC, 2026).

Conclusion

Memorizing the CTFPHC screening guidelines is essential to passing the preventive care section of the MCCQE Part 1. Focus your study on the starting ages for cervical screening, mammogram intervals, and the smoking history criteria for lung cancer screening.

• Remember that cervical screening starts at age 25 and is done every 3 years.
• Colorectal screening FIT/FOBT is done every 2 years for ages 50 to 74.
• Know the criteria for lung cancer screening: 30 pack-years, aged 55 to 74.

To practice preventive screening scenarios with clinical questions, sign up for a Canadian-focused question bank.